Similar articles

• Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease.

  Rose EH, Aledort LM. Rose EH, et al. Ann Intern Med. 1991 Apr 1;114(7):563-8. doi: 10.7326/0003-4819-114-7-563. Ann Intern Med. 1991. PMID: 1900403
• Intranasal and intravenous administration of desmopressin: effect on F VIII/vWF, pharmacokinetics and reproducibility.

  Lethagen S, Harris AS, Sjörin E, Nilsson IM. Lethagen S, et al. Thromb Haemost. 1987 Dec 18;58(4):1033-6. Thromb Haemost. 1987. PMID: 3127915
• High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A.

  Leissinger C, Becton D, Cornell C Jr, Cox Gill J. Leissinger C, et al. Haemophilia. 2001 May;7(3):258-66. doi: 10.1046/j.1365-2516.2001.00500.x. Haemophilia. 2001. PMID: 11380629 Clinical Trial.
• Perioperative Desmopressin for Patients Undergoing Otolaryngologic Procedures: A Systematic Review.

  Barinsky GL, Buziashvili D, Svider PF, Carron MA, Folbe AJ, Hsueh WD, Eloy JA, Johnson AP. Barinsky GL, et al. Otolaryngol Head Neck Surg. 2019 Jul;161(1):36-45. doi: 10.1177/0194599819831288. Epub 2019 Mar 12. Otolaryngol Head Neck Surg. 2019. PMID: 30857487
• Life threatening biphasic adverse reactions to desmopressin: case report and review of the literature.

  Wang L, Chen R, Tian F, Wang W, Wang L, Yu B, Huang X, Zhang Y, Su S, Ma G, Wang K. Wang L, et al. Int J Clin Pharmacol Ther. 2016 Aug;54(8):640-4. doi: 10.5414/CP202461. Int J Clin Pharmacol Ther. 2016. PMID: 27142268 Review.